Dunlop A. Sinclair — SEC Form 4 filings
SEC reporting owner CIK 1721108. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-14.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-20 to 2026-05-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 185,957 shares, $6,013,748 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 35,305 shares @ $39.22 ($1,384,662) in Apellis Pharmaceuticals, Inc., filed 2024-06-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) | Director | 12 | — | 8 legs · 185,957 sh · $6,013,748 | 26 |
Form 4 filings — Dunlop A. Sinclair
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Code (U): 161,567 · Disposition to issuer (D): 3,062 · Disposition to issuer (D): 5,744 · Disposition to issuer (D): 7,961 · Disposition to issuer (D): 3,544 · Disposition to issuer (D): 14,684 (derivative) · +6 more | EDGAR |
| 2026-01-05 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 7,961 @ $0 · Grant/award (A): 14,684 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Other (J): 4,787 @ $0 · Sale (S): 31,092 @ $23.72 · Other (J): 3,837 @ $0 | EDGAR |
| 2025-10-02 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 31,092 @ $22.58 · Other (J): 3,837 @ $0 | EDGAR |
| 2025-09-19 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 31,092 @ $22.95 · Other (J): 3,837 @ $0 | EDGAR |
| 2025-01-03 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 6,267 @ $0 · Grant/award (A): 11,199 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 4,600 @ $13.19 · Option exercise (M): 4,600 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 29,476 @ $36.09 · Sale (S): 7,524 @ $36.79 | EDGAR |
| 2024-07-01 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 900 @ $13.19 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 35,305 @ $39.22 · Sale (S): 1,695 @ $39.63 | EDGAR |
| 2024-04-15 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 1,500 @ $13.19 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 18,681 @ $57.18 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1721108 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →